Clinical trial
Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With…
NCT00065572 · AstraZeneca, Industry · Suspended
Key facts
| NCT number | NCT00065572 |
|---|---|
| Title | Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV) |
| Lead sponsor | AstraZeneca, Industry |
| Status | Suspended |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Renal Cell, Kidney Neoplasms |
| Intervention type | Drug |
| Interventions | ZD6126, Placebo |
| Start date | Aug 1, 2003 |
| Primary completion | Feb 1, 2004 |
| Completion | Feb 1, 2004 |
| First posted | Jul 31, 2003 |
| Last update posted | Jan 26, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: